Larry J. Black

Raloxifene (LY139481 HCI) prevents bone loss and reduces serum cholesterol without causing uterine hypertrophy in ovariectomized rats.

Larry J. Black, Masahiko Sato, Ellen R. Rowley et al. · Journal of Clinical Investigation · 1994 · 612 citations · Full text

Lipid Peroxidation, Gynecology, Pharmacotherapy +20

Antiestrogens. 2. Structure-activity studies in a series of 3-aroyl-2-arylbenzo[b]thiophene derivatives leading to [6-hydroxy-2-(4-hydroxyphenyl)benzo[b]thien-3-yl]-[4-[2-(1-piperidinyl)ethoxy]phenyl]methanone hydrochloride (LY 156758), a remarkably effective estrogen antagonist with only minimal intrinsic estrogenicity

Charles D. Jones, Mary G. Jevnikar, Andrew Pike et al. · Journal of Medicinal Chemistry · 1984 · 282 citations

Antagonism of estrogen action with a new benzothiophene derived antiestrogen

Larry J. Black, C. David Jones, Julie F. Falcone · Life Sciences · 1983 · 242 citations

Endocrine Disruptors, Medicinal Chemistry, Medicine +9

Effects of a new antiestrogen, keoxifene (LY156758), on growth of carcinogen-induced mammary tumors and on LH and prolactin levels

James A. Clemens, D.R. Bennett, Larry J. Black et al. · Life Sciences · 1983 · 176 citations

New Antiestrogen, Breast Oncology, Medicine +9

Uterine bioassay of tamoxifen, trioxifene and a new estrogen antagonist (LY117018) in rats and mice

Larry J. Black, Robin L. Goode · Life Sciences · 1980 · 135 citations

Uterine Bioassay, Hormonal Contraceptive, Medicine +9